Several inflammatory signaling pathways, such as NF-κB, JAK/STAT, and PI3K/AKT, provide prosurvival and proliferative signals to developing CRC cells, and genetic inhibition of these pathways uniformly reduces inflammation and tumor number (20, 22, 74). The gene discussed is AKT1; the disease is neoplasm.